# Biological Standardization of Dactylis Glomerata Allergen Extract

> **NCT01407835** · PHASE2 · COMPLETED · sponsor: **Laboratorios Leti, S.L.** · enrollment: 31 (actual)

## Conditions studied

- Allergy to Grass Pollen (Dactylis Glomerata)

## Interventions

- **BIOLOGICAL:** Four different concentrations of Dactylis glomerata allergen extract, positive control and negative control

## Key facts

- **NCT ID:** NCT01407835
- **Lead sponsor:** Laboratorios Leti, S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2012-03
- **Final completion:** 2012-06
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2012-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01407835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01407835, "Biological Standardization of Dactylis Glomerata Allergen Extract". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01407835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*